Evidence map›Paper›PMID 23967339›Full record

ArticlePloS one2013

ICOS-expressing lymphocytes promote resolution of CD8-mediated lung injury in a mouse model of lung rejection.

Qiang Wu, Gail J Gardiner, Elizabeth Berry, Sarah R Wagner, Tiffany Lu, Bryan S Clay, Tamson V Moore, Caroline M Ferreira, Jesse W Williams, Andrew D Luster and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Bone & joint research · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Qiang WuCenter for Immunobiology, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Gail J Gardiner
Elizabeth Berry
Sarah R Wagner
Tiffany Lu
Bryan S Clay
Tamson V Moore
Caroline M Ferreira
Jesse W Williams
Andrew D Luster
Benjamin D Medoff
Judy L Cannon
Anne I Sperling
Rebecca A Shilling
University of Chicago · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineHarvard University · USMassachusetts General Hospital · US

Funding

IP 10--ITS ROLE IN INFLAMMATION AND CANCER THERAPYR01CA069212 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 1996 to 2014
$5.6M
IL-17 and Lung Transplant Obliterative BronchiolitisR01HL109310 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHILLING, REBECCA A. · 2011 to 2015
$1.9M
Mechanisms of Resolution in Experimental AsthmaR01AI067697 · NIAID · UNIVERSITY OF CHICAGO · PI SPERLING, ANNE I. · 2007 to 2011
$1.9M
ICOS Expression Levels and Th DevelopmentK08AI059105 · NIAID · UNIVERSITY OF CHICAGO · PI SHILLING, REBECCA A. · 2006 to 2010
$576k
NCI NIH HHS R01 CA069212NCI NIH HHS R01CA069212NIAID NIH HHS K08 AI059105NIAID NIH HHS K08AI059105NIAID NIH HHS R01 AI067697NIAID NIH HHS R01AI67697
6 · The paper itself

Abstract

Acute rejection, a common complication of lung transplantation, may promote obliterative bronchiolitis leading to graft failure in lung transplant recipients. During acute rejection episodes, CD8(+) T cells can contribute to lung epithelial injury but the mechanisms promoting and controlling CD8-mediated injury in the lung are not well understood. To study the mechanisms regulating CD8(+) T cell-mediated lung rejection, we used a transgenic model in which adoptively transferred ovalbumin (OVA)-specific cytotoxic T lymphocytes (CTL) induce lung injury in mice expressing an ovalbumin transgene in the small airway epithelium of the lungs (CC10-OVA mice). The lung pathology is similar to findings in humans with acute lung transplant. In the presence of an intact immune response the inflammation resolves by day 30. Using CC10-OVA.RAG(-/-) mice, we found that CD4(+) T cells and ICOS(+/+) T cells were required for protection against lethal lung injury, while neutrophil depletion was not protective. In addition, CD4(+)Foxp3 (+) ICOS(+) T cells were enriched in the lungs of animals surviving lung injury and ICOS(+/+) Tregs promoted survival in animals that received ICOS(-/-) T cells. Direct comparison of ICOS(-/-) Tregs to ICOS(+/+) Tregs found defects in vitro but no differences in the ability of ICOS(-/-) Tregs to protect from lethal lung injury. These data suggest that ICOS affects Treg development but is not necessarily required for Treg effector function.

Indexed as

AnimalsAntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationDisease Models, AnimalGene ExpressionGene Knockdown TechniquesGraft RejectionInducible T-Cell Co-Stimulator ProteinInflammationInterleukin-10Interleukin-2Lung InjuryLung TransplantationLymphocyte SubsetsAntigensInducible T-Cell Co-Stimulator ProteinInterleukin-10Interleukin-2

Identifiers

PMID23967339
PMCPMC3742557
OpenAlexW2157236130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.